196 related articles for article (PubMed ID: 16803471)
21. Uterine papillary serous carcinoma (pure and mixed type) compared with moderately and poorly differentiated endometrioid carcinoma. A clinicopathologic study.
Halperin R; Zehavi S; Langer R; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 2002; 23(4):300-4. PubMed ID: 12214728
[TBL] [Abstract][Full Text] [Related]
22. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
Kwon JS; Abrams J; Sugimoto A; Carey MS
Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450
[TBL] [Abstract][Full Text] [Related]
23. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
[TBL] [Abstract][Full Text] [Related]
24. The importance of chemotherapy and radiation in uterine papillary serous carcinoma.
Viswanathan AN; Macklin EA; Berkowitz R; Matulonis U
Gynecol Oncol; 2011 Dec; 123(3):542-7. PubMed ID: 21963091
[TBL] [Abstract][Full Text] [Related]
25. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
26. Uterine papillary serous carcinoma.
Moore KN; Fader AN
Clin Obstet Gynecol; 2011 Jun; 54(2):278-91. PubMed ID: 21508697
[TBL] [Abstract][Full Text] [Related]
27. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study.
Kim M; Kwon BS; Chang HK; Lee S; Chang SJ; Choi JY; Park SY; Lee M; Ryu HS; Kim YB
J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761
[TBL] [Abstract][Full Text] [Related]
28. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
29. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.
Rauh-Hain JA; Growdon WB; Schorge JO; Goodman AK; Boruta DM; McCann C; Horowitz NS; del Carmen MG
Gynecol Oncol; 2010 Nov; 119(2):299-304. PubMed ID: 20691465
[TBL] [Abstract][Full Text] [Related]
30. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma.
Hamilton CA; Cheung MK; Osann K; Balzer B; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
Gynecol Oncol; 2006 Nov; 103(2):679-83. PubMed ID: 16793126
[TBL] [Abstract][Full Text] [Related]
31. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
Carcangiu ML; Chambers JT
Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
[TBL] [Abstract][Full Text] [Related]
32. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.
Tchabo NE; McCloskey S; Mashtare TL; Andrews C; Singh AK; Mhawech-Fauceglia P; Odunsi K; Lele S; Jaggernauth W
Gynecol Oncol; 2009 Nov; 115(2):249-56. PubMed ID: 19692115
[TBL] [Abstract][Full Text] [Related]
33. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.
Growdon WB; Rauh-Hain JJ; Cordon A; Garrett L; Schorge JO; Goodman A; Boruta DM; Horowitz NS; del Carmen MG
Int J Gynecol Cancer; 2012 Mar; 22(3):417-24. PubMed ID: 22237383
[TBL] [Abstract][Full Text] [Related]
34. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
35. Utility of radiation therapy for early-stage uterine papillary serous carcinoma.
Cham S; Huang Y; Tergas AI; Hou JY; Burke WM; Deutsch I; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2017 May; 145(2):269-276. PubMed ID: 28343693
[TBL] [Abstract][Full Text] [Related]
36. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
38. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
[TBL] [Abstract][Full Text] [Related]
39. Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma.
Bancher-Todesca D; Neunteufel W; Williams KE; Prainsack D; Breitenecker G; Friedlander ML; Hacker NF
Gynecol Oncol; 1998 Dec; 71(3):344-7. PubMed ID: 9887228
[TBL] [Abstract][Full Text] [Related]
40. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]